A new inhibitor of apoptosis from vaccinia virus and eukaryotes.
Publication year
2007Source
Plos Pathogens, 3, 2, (2007), pp. e17ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Medical Microbiology
Journal title
Plos Pathogens
Volume
vol. 3
Issue
iss. 2
Page start
p. e17
Page end
p. e17
Subject
N4i 1: Pathogenesis and modulation of inflammation; NCMLS 1: Immunity, infection and tissue repair; NCMLS 1: Infection and autoimmunity; UMCN 4.1: Microbial pathogenesis and host defenseAbstract
A new apoptosis inhibitor is described from vaccinia virus, camelpox virus, and eukaryotic cells. The inhibitor is a hydrophobic, multiple transmembrane protein that is resident in the Golgi and is named GAAP (Golgi anti-apoptotic protein). Stable expression of both viral GAAP (v-GAAP) and human GAAP (h-GAAP), which is expressed in all human tissues tested, inhibited apoptosis induced by intrinsic and extrinsic apoptotic stimuli. Conversely, knockout of h-GAAP by siRNA induced cell death by apoptosis. v-GAAP and h-GAAP display overlapping functions as shown by the ability of v-GAAP to complement for the loss of h-GAAP. Lastly, deletion of the v-GAAP gene from vaccinia virus did not affect virus replication in cell culture, but affected virus virulence in a murine infection model. This study identifies a new regulator of cell death that is highly conserved in evolution from plants to insects, amphibians, mammals, and poxviruses.
This item appears in the following Collection(s)
- Academic publications [246860]
- Electronic publications [134292]
- Faculty of Medical Sciences [93474]
- Open Access publications [107812]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.